AS
Amit Suri
About Amit Suri
Data last updated:
Amit Suri is a Director at Supriti Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Supriti Pharmaceuticals Private Limited reported revenue of ₹59.9 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Supriti Pharmaceuticals Private Limited U24239UR2020PTC011868 | Director | 05 Jan 2021 | 2020 | ₹59.9 Lakh (FY 2022) | Active |
Board colleagues of Amit Suri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nishad Arora | 09019707 | Supriti Pharmaceuticals Private Limited | Director |
| Preetika Suri | 08994777 | Supriti Pharmaceuticals Private Limited | Director |
| Sunita Jolly | 08994778 | Supriti Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amit Suri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amit Suri
Amit Suri currently holds 1 directorship: Supriti Pharmaceuticals Private Limited (Director, since 05 Jan 2021, revenue ₹59.9 Lakh (FY 2022)).
Amit Suri was first appointed on 05 Jan 2021 as Director at Supriti Pharmaceuticals Private Limited.
The current boards of Amit Suri's companies include Nishad Arora (Supriti Pharmaceuticals Private Limited), Preetika Suri (Supriti Pharmaceuticals Private Limited), Sunita Jolly (Supriti Pharmaceuticals Private Limited).